Faculty Opinions recommendation of Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study.

2018 ◽  
Author(s):  
Coen Stehouwer ◽  
Martijn Brouwers
Keyword(s):  
Crossover Study ◽  
Healthy Volunteers ◽  
Dihydroxyvitamin D ◽  
1,25 Dihydroxyvitamin D ◽  
Randomized Crossover Study

scholarly journals Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study

JCI Insight ◽  
2018 ◽  
Vol 3 (8) ◽  
Author(s):  
Jenny E. Blau ◽  
Viviana Bauman ◽  
Ellen M. Conway ◽  
Paolo Piaggi ◽  
Mary F. Walter ◽  
...  
Keyword(s):  
Crossover Study ◽  
Healthy Volunteers ◽  
Dihydroxyvitamin D ◽  
1,25 Dihydroxyvitamin D ◽  
Randomized Crossover Study

Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open-Label, Multiple-Dose, Randomized, Crossover Study

2012 ◽  
Vol 52 (8) ◽  
pp. 1255-1264 ◽  
Author(s):  
Georgina Cirrincione-Dall ◽  
Barbara J. Brennan ◽  
Rosa M. Ballester-Sanchis ◽  
Mercidita T. Navarro ◽  
Brian E. Davies
Keyword(s):  
Crossover Study ◽  
Healthy Volunteers ◽  
Multiple Dose ◽  
Open Label ◽  
Randomized Crossover Study

scholarly journals Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers

2017 ◽  
Vol 37 (10) ◽  
pp. 937-946 ◽  
Author(s):  
Arindam Pal ◽  
Srinivas Shenoy ◽  
Anirudh Gautam ◽  
Sagar Munjal ◽  
Jing Niu ◽  
...  
Keyword(s):  
Crossover Study ◽  
Healthy Volunteers ◽  
Oral Solution ◽  
Randomized Crossover Study
Sign in / Sign up

Export Citation Format

Share Document